Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Law Firm Supports Fund To Help Further Dermatology Therapies

By Pepper Hamilton LLP | April 12, 2018

Advancing Innovation in Dermatology (AID) has announced the launch of its AID Accelerator Fund to provide economic and intellectual capital to further a discovery’s potential for commercialization. 

Pepper Hamilton LLP partners Raymond A. Miller and N. Nicole Stakleff, and of counsel, David S. Smith, attorneys in the firm’s Health Sciences Department, are providing pro bono services to individuals and organizations supported by the fund.

The AID Accelerator Fund was designed to help advance product development of important scientific discoveries and support new early-stage technologies that have the potential to improve skin health. In addition to in-kind business support, the fund offers seed funding and access to an ecosystem of dermatologic product innovation.

“The intellectual property issues faced by early-stage companies with innovative therapies can be challenging,” said Raymond Miller. “Combining relevant dermatology experience with an early-stage funding mechanism provides a fertile ground allowing innovation to flourish. As a leading health science law firm, Pepper Hamilton remains committed to helping AID bridge the gap between research and commercialization.”

The fund is designed to connect institutional research funding and traditional venture capital. It offers IP and advisory services to develop and advance invention toward commercialization, as well as early financial support. The AID Accelerator Fund is currently seeking early-stage research and development products that are not yet at the venture funding stage.

Awardees will be determined by the AID Accelerator Fund’s Steering Committee, which will consider products that have a direct relevance to unmet needs in dermatology and demonstrate significant likelihood of success.

“Pepper Hamilton is committed to assisting start-ups and early-stage companies that have the potential to significantly impact economic development,” said Nicole Stakleff. “By providing advisory support to promising projects, we hope to help bring dermatologic breakthroughs to fruition.”

The AID Accelerator Fund is featured in the April 11 issue of the Journal of American Medicine Association (JAMA) Dermatology. 

Pepper Hamilton LLP, founded in 1890, has more than 425 lawyers in 13 offices across the United States.

(Source: Pepper Hamilton LLP)


Filed Under: Drug Discovery

 

Related Articles Read More >

Red blood cells macro over red eritrosit background. Concept of blood cells count, medicine and healthcare. 3d rendering mock up
Platelet-inspired nanoparticle delivers drugs directly where they are needed
Lilly’s triple agonist delivers up to 71.2 lbs of weight loss in Phase 3 trial
China’s biopharma sector enters ‘innovation 2.0’ era
The FDA’s AI ambitions depend on better data practices
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE